Embla Medical - Recording of Q2 2025 results presentation
Today, Embla Medical's CEO, Sveinn Sölvason, presented the Q2/H1 2025 results, along with an update to the 2025 guidance, in which the company revised down the top of its growth expectations.
He also discussed the strategic rationale behind the latest acquisition. During the Q&A session, the focus, among other topics, was on the potential effects of tariffs and the impact of the new political landscape.
You can watch a recording of the presentation here: https://www.inderes.dk/videos/embla-medical-presentation-of-q2-2025-interim-report
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR agreement. /Michael Friis 13:30, 22/07/2025.
